Table 3.
Correlation analysis of clinical characteristics of IGM with patient age and BMI at presentation.
| Characteristics | All patients (n = 44) | Patients with recurrence (n = 14) | ||||||
|---|---|---|---|---|---|---|---|---|
| Age, years | BMI, kg/m2 | Age, years | BMI, kg/m2 | |||||
| rho | p-value | rho | p-value | rho | p-value | rho | p-value | |
| Size of mass at presentation, cm | 0.038 | 0.862 | −0.570 | 0.007 ∗ | −0.241 | 0.566 | −0.879 | 0.009 ∗ |
| Duration for presence of mass, months | −0.049 | 0.809 | 0.230 | 0.280 | −0.182 | 0.615 | 0.025 | 0.948 |
| Duration of prednisolone treatment, weeks | 0.326 | 0.327 | 0.350 | 0.322 | 0.754 | 0.084 | 0.543 | 0.266 |
| Size of tissue removed, cm | −0.001 | 0.995 | 0.145 | 0.509 | 0.428 | 0.218 | 0.168 | 0.666 |
| Ratio between mass size and removed tissue | 0.467 | 0.092 | −0.286 | 0.368 | 0.410 | 0.493 | 0.211 | 0.789 |
| Time to recurrence, months | — | — | — | — | −0.836 | 0.003 ∗ | −0.232 | 0.548 |
| Number of recurrence episodes | — | — | — | — | 0.102 | 0.766 | 0.172 | 0.636 |
| Size of recurrence mass, cm | — | — | — | — | −0.633 | 0.127 | 0.087 | 0.870 |
rho, Spearman's correlation coefficient. ∗Indicates statistical significance at p < 0.05. BMI, body mass index.
Bold values represent statistically significant findings in correlation analysis.